Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.drudis.2020.02.011 http://scihub22266oqcxt.onion/10.1016/j.drudis.2020.02.011 32198066!7102657!32198066     free     free     free Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Drug+Discov+Today 2020 ; 25 (5): 810-812 Nephropedia Template TP {{tp|p=32198066|t=2020. Advance of promising targets and agents against COVID-19 in China |pdf=|usr=}}{{32198066}} gab.com Text Advance of promising targets and agents against COVID-19 in China JO: Drug Discov Today http://www.kidney.de/pget.php?&tw=1&pmid=32198066 #FOAvip ä Twit Text FOAVip Advance of promising targets and agents against COVID-19 in China ????Drug Discov Today http://www.kidney.de/pget.php?&tw=1&pmid=32198066 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32198066 #FOAvip English Wikipedia <ref>{{Cite pmid|32198066}}</ref> Advance of promising targets and agents against COVID-19 in China #MMPMID32198066 Duan Y; Zhu HL; Zhou C Drug Discov Today 2020[May]; 25 (5): 810-812 PMID32198066show ga ä |Adenine/analogs & derivatives/therapeutic use[MESH] |Adenosine Monophosphate/analogs & derivatives/therapeutic use[MESH] |Alanine/analogs & derivatives/therapeutic use[MESH] |Amides/therapeutic use[MESH] |Antimalarials/therapeutic use[MESH] |Antiviral Agents/*therapeutic use[MESH] |Betacoronavirus/*metabolism[MESH] |COVID-19[MESH] |COVID-19 Drug Treatment[MESH] |China[MESH] |Chloroquine/therapeutic use[MESH] |Clinical Trials as Topic[MESH] |Cobicistat/therapeutic use[MESH] |Coronavirus 3C Proteases[MESH] |Coronavirus Infections/*drug therapy[MESH] |Cysteine Endopeptidases/metabolism[MESH] |Dibenzothiepins[MESH] |Drug Combinations[MESH] |Drug Discovery[MESH] |Drug Therapy, Combination[MESH] |Emtricitabine/therapeutic use[MESH] |Humans[MESH] |Hydroxychloroquine/therapeutic use[MESH] |Indoles/therapeutic use[MESH] |Lopinavir/therapeutic use[MESH] |Medicine, Chinese Traditional[MESH] |Morpholines[MESH] |Oseltamivir/therapeutic use[MESH] |Oxazines/therapeutic use[MESH] |Pandemics[MESH] |Pneumonia, Viral/*drug therapy[MESH] |Pyrazines/therapeutic use[MESH] |Pyridines/therapeutic use[MESH] |Pyridones[MESH] |RNA-Dependent RNA Polymerase/metabolism[MESH] |Ritonavir/therapeutic use[MESH] |SARS-CoV-2[MESH] |Spike Glycoprotein, Coronavirus/metabolism[MESH] |Tenofovir/therapeutic use[MESH] |Thiepins/therapeutic use[MESH] |Triazines/therapeutic use[MESH]Advance of promising targets and agents against COVID-19 in China (epmc).pdf DeepDyve Pubget Overpricing